Compare PCRX & APC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | APC |
|---|---|---|
| Founded | 2006 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 892.9M |
| IPO Year | 2010 | 2025 |
| Metric | PCRX | APC |
|---|---|---|
| Price | $25.17 | $15.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $30.00 | $22.25 |
| AVG Volume (30 Days) | ★ 464.2K | 131.5K |
| Earning Date | 11-05-2026 | 11-13-2026 |
| Dividend Yield | N/A | ★ 12.90% |
| EPS Growth | ★ 107.44 | N/A |
| EPS | 0.19 | ★ 0.46 |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $3.85 | $14.55 |
| Revenue Next Year | $4.69 | N/A |
| P/E Ratio | $131.63 | ★ $32.67 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $14.50 |
| 52 Week High | $27.66 | $21.72 |
| Indicator | PCRX | APC |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 35.33 |
| Support Level | $24.61 | N/A |
| Resistance Level | $25.17 | $19.35 |
| Average True Range (ATR) | 0.81 | 0.74 |
| MACD | 0.03 | -0.25 |
| Stochastic Oscillator | 68.40 | 30.15 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Arko Petroleum Corp is a fuel distribution company. It operates through three reportable segments: i) Wholesale: Distributes fuel to gas stations, sub-wholesalers, and bulk purchasers, typically under long-term contracts on a cost-plus or consignment basis. ii) Fleet Fueling: Operates proprietary and third-party cardlock locations serving commercial and municipal fleets, and earns commissions from proprietary fuel card sales. iii) GPMP: Supplies fuel to ARKO Retail Sites at cost plus a fixed margin, charges fixed fees to certain sites. The company generates the majority of revenue from the Wholesale segment.